MediWound Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About MediWound Ltd
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
/ 
Frequently asked questions
To buy MediWound Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MediWound Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MediWound Ltd is MDWD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MediWound Ltd has its primary listing on NASDAQ. You can trade MediWound Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MediWound Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include MediWound Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like MediWound Ltd.